• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低骨骼肌质量指数和围手术期输血对肝癌根治性切除术后预后的影响。

Impact of low skeletal muscle mass index and perioperative blood transfusion on the prognosis for HCC following curative resection.

作者信息

Bekki Tomoaki, Abe Tomoyuki, Amano Hironobu, Hattori Minoru, Kobayashi Tsuyoshi, Nakahara Masahiro, Ohdan Hideki, Noriyuki Toshio

机构信息

Department of Surgery, Onomichi General Hospital, 1-10-23 Hirahara, Onomichi, Hiroshima, Japan.

Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Kasumi 1-2-3 Minami-ku, Hiroshima, Japan.

出版信息

BMC Gastroenterol. 2020 Oct 7;20(1):328. doi: 10.1186/s12876-020-01472-z.

DOI:10.1186/s12876-020-01472-z
PMID:33028209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7539410/
Abstract

BACKGROUND

This study aimed to assess the prognostic factors including low skeletal muscle mass index (SMI) and perioperative blood transfusion for patients with hepatocellular carcinoma (HCC) following curative surgery.

METHODS

This study included 139 patients with HCC who underwent hepatectomy between 2005 and 2016. Univariate and multivariate analyses were performed to identify variables associated with overall survival (OS) and recurrence-free survival (RFS).

RESULTS

Low SMI was significantly related with poor OS, while blood transfusion had a strong impact on RFS. The male ratio and body mass index in the low SMI group were significantly higher than those in the high SMI group. There were no significant differences in age, virus etiology, laboratory data, liver function, tumor makers, and operative variables between the groups. Tumor factors such as tumor diameter, tumor number, poor differentiation, and intrahepatic metastasis (IM) did not significantly differ between the two groups. Operation time, intraoperative blood loss volume, and recurrence ratio were significantly higher in the blood transfusion group than in the non-transfusion group. IM was associated with poor OS and RFS.

CONCLUSIONS

Low SMI and blood transfusion were independently related with long-term prognosis in patients with HCC following curative surgery.

摘要

背景

本研究旨在评估肝细胞癌(HCC)根治性手术后患者的预后因素,包括低骨骼肌质量指数(SMI)和围手术期输血情况。

方法

本研究纳入了2005年至2016年间接受肝切除术的139例HCC患者。进行单因素和多因素分析以确定与总生存期(OS)和无复发生存期(RFS)相关的变量。

结果

低SMI与较差的OS显著相关,而输血对RFS有强烈影响。低SMI组的男性比例和体重指数显著高于高SMI组。两组在年龄、病毒病因、实验室数据、肝功能、肿瘤标志物和手术变量方面无显著差异。两组之间的肿瘤直径、肿瘤数量、低分化和肝内转移(IM)等肿瘤因素无显著差异。输血组的手术时间、术中失血量和复发率显著高于非输血组。IM与较差的OS和RFS相关。

结论

低SMI和输血与HCC根治性手术后患者的长期预后独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd50/7539410/89f61e41af77/12876_2020_1472_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd50/7539410/281086e38a97/12876_2020_1472_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd50/7539410/89f61e41af77/12876_2020_1472_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd50/7539410/281086e38a97/12876_2020_1472_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd50/7539410/89f61e41af77/12876_2020_1472_Fig2_HTML.jpg

相似文献

1
Impact of low skeletal muscle mass index and perioperative blood transfusion on the prognosis for HCC following curative resection.低骨骼肌质量指数和围手术期输血对肝癌根治性切除术后预后的影响。
BMC Gastroenterol. 2020 Oct 7;20(1):328. doi: 10.1186/s12876-020-01472-z.
2
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
3
Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.围手术期异体输血对不同分期肝癌根治术后患者长期预后的影响。
Eur J Surg Oncol. 2021 Mar;47(3 Pt B):620-627. doi: 10.1016/j.ejso.2020.09.021. Epub 2020 Sep 21.
4
Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.围手术期输血并不影响肝癌根治性切除术后的无复发生存率和总生存率:倾向评分匹配分析。
J Hepatol. 2016 Mar;64(3):583-93. doi: 10.1016/j.jhep.2015.10.012. Epub 2015 Oct 24.
5
Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma.肝细胞癌根治性肝切除术后围手术期输血与生存情况
Hepatogastroenterology. 2005 Mar-Apr;52(62):524-9.
6
Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in Child-Pugh class A patients.在Child-Pugh A级患者中,肝切除术后输血与肝细胞癌复发相关。
World J Surg. 2015 Apr;39(4):1044-51. doi: 10.1007/s00268-014-2891-6.
7
No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis.围手术期输血对肝癌根治性切除术后预后无影响:倾向评分匹配分析。
Clin Transl Oncol. 2018 Jun;20(6):719-728. doi: 10.1007/s12094-017-1773-4. Epub 2017 Oct 27.
8
The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.围手术期输血对肝细胞癌根治性切除术后肝内复发的影响。
Am J Gastroenterol. 2000 May;95(5):1294-300. doi: 10.1111/j.1572-0241.2000.02028.x.
9
[Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].[不同中国肝癌分期肝细胞癌患者根治性肝切除术后的临床疗效及预后因素分析]
Zhonghua Wai Ke Za Zhi. 2021 Feb 1;59(2):134-143. doi: 10.3760/cma.j.cn112139-20200803-00605.
10
Effect of perioperative factors on the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy.围手术期因素对接受肝切除术的肝细胞癌患者预后的影响。
Turk J Med Sci. 2022 Aug;52(4):1067-1074. doi: 10.55730/1300-0144.5409. Epub 2022 Aug 10.

引用本文的文献

1
Association of preoperative muscle-adipose index measured by computed tomography with survival in patients with esophageal squamous cell carcinoma.术前 CT 测量的肌肉-脂肪指数与食管鳞癌患者生存的关系。
World J Surg Oncol. 2024 Feb 22;22(1):61. doi: 10.1186/s12957-024-03338-0.
2
A systematic review and meta-analysis of blood transfusion rates during liver resection by country.按国家对肝切除术中输血率进行的系统评价和荟萃分析。
Ann Surg Treat Res. 2023 Dec;105(6):404-416. doi: 10.4174/astr.2023.105.6.404. Epub 2023 Nov 29.
3
Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis.

本文引用的文献

1
Comparison of new prognostic systems for patients with resectable hepatocellular carcinoma: Albumin-Bilirubin grade and Albumin-Indocyanine Green Evaluation grade.可切除肝细胞癌患者新预后系统的比较:白蛋白-胆红素分级和白蛋白-吲哚菁绿评估分级
Hepatol Res. 2019 Oct;49(10):1218-1226. doi: 10.1111/hepr.13393. Epub 2019 Jul 10.
2
Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.围手术期输血与远端胆管癌切除术后复发和生存的关系:来自美国肝外胆管恶性肿瘤联盟的 10 个机构研究。
Ann Surg Oncol. 2019 Jun;26(6):1814-1823. doi: 10.1245/s10434-019-07306-x. Epub 2019 Mar 15.
3
肌肉减少症和肌肉减少性肥胖对原发性肝癌患者生存的影响:一项系统评价和荟萃分析。
Front Nutr. 2023 Oct 19;10:1233973. doi: 10.3389/fnut.2023.1233973. eCollection 2023.
4
Effect of Perioperative Blood Transfusion on the Postoperative Prognosis of Ruptured Hepatocellular Carcinoma Patients With Different BCLC Stages: A Propensity Score Matching Analysis.围手术期输血对不同BCLC分期的破裂肝细胞癌患者术后预后的影响:一项倾向评分匹配分析
Front Surg. 2022 Mar 22;9:863790. doi: 10.3389/fsurg.2022.863790. eCollection 2022.
5
Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy.腰大肌质量指数与中性粒细胞/淋巴细胞比值联合作为非手术治疗肝细胞癌患者的预后预测指标
JGH Open. 2021 Nov 19;5(12):1335-1343. doi: 10.1002/jgh3.12676. eCollection 2021 Dec.
6
Sarcopenia is associated with blood transfusions in head and neck cancer free flap surgery.肌少症与头颈癌游离皮瓣手术中的输血有关。
Laryngoscope Investig Otolaryngol. 2021 Jan 31;6(2):200-210. doi: 10.1002/lio2.530. eCollection 2021 Apr.
Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma.
术前中性粒细胞与淋巴细胞比值可预测早期胰腺导管腺癌的预后。
Eur J Surg Oncol. 2018 Oct;44(10):1573-1579. doi: 10.1016/j.ejso.2018.04.022. Epub 2018 May 5.
4
Perioperative transfusion in pancreatoduodenectomy: The double-edged sword of pancreatic surgeons.胰十二指肠切除术中的围手术期输血:胰腺外科医生的双刃剑。
Medicine (Baltimore). 2017 Dec;96(49):e9019. doi: 10.1097/MD.0000000000009019.
5
Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis.围手术期异体输血是肝细胞癌手术后预后不良的因素:一项多中心分析。
Surg Today. 2018 Jan;48(1):73-79. doi: 10.1007/s00595-017-1553-3. Epub 2017 Jun 8.
6
Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma.格拉斯哥预后评分与肝细胞癌肝切除术后的预后
World J Surg. 2017 Jul;41(7):1860-1870. doi: 10.1007/s00268-017-3909-7.
7
Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma.肝细胞癌患者术后肝内转移和多中心发生的不同复发风险因素
J Gastrointest Surg. 2017 Feb;21(2):312-320. doi: 10.1007/s11605-016-3311-z. Epub 2016 Nov 4.
8
Inflammation-based Prognostic Score in Patients with Living Donor Liver Transplantation for Hepatocellular Carcinoma.肝细胞癌活体肝移植患者基于炎症的预后评分
Anticancer Res. 2016 Oct;36(10):5537-5542. doi: 10.21873/anticanres.11137.
9
Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.围手术期输血并不影响肝癌根治性切除术后的无复发生存率和总生存率:倾向评分匹配分析。
J Hepatol. 2016 Mar;64(3):583-93. doi: 10.1016/j.jhep.2015.10.012. Epub 2015 Oct 24.
10
Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment.肌肉减少症是肝细胞癌根治性治疗后复发的一个危险因素。
Hepatol Res. 2016 Feb;46(2):201-8. doi: 10.1111/hepr.12562. Epub 2015 Aug 18.